Brief: CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients

March 24 (Reuters) - CEL-SCI Corp CVM.A:

CEL-SCI REPORTS NEW DATA: TREATMENT WITH MULTIKINE RESULTED IN UP TO 95% IMPROVEMENT IN QUALITY OF LIFE FOR HEAD AND NECK CANCER PATIENTS

Source text: ID:nBwbxyWY6a

Further company coverage: CVM.A

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on CEL-SCI

See all news